Authors:
Kandzari, DE
Lam, LC
Eisenstein, EL
Clapp-Channing, N
Fine, JT
Califf, RM
Mark, DB
Jollis, JG
Citation: De. Kandzari et al., Advanced coronary artery disease: Appropriate end points for trials of novel therapies, AM HEART J, 142(5), 2001, pp. 843-851
Citation: El. Eisenstein et Db. Mark, Cost-effectiveness of new diagnostic tools and therapies for acute coronary syndromes, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 811-844
Authors:
Eisenstein, EL
Peterson, ED
Jollis, JG
Tardiff, BE
Califf, RM
Knight, JD
Mark, DB
Citation: El. Eisenstein et al., Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome, PHARMACOECO, 17(3), 2000, pp. 263-272
Authors:
Stowers, SA
Eisenstein, EL
Wackers, FJT
Berman, DS
Blackshear, JL
Jones, AD
Szymanski, TJ
Lam, LC
Simons, TA
Natale, D
Citation: Sa. Stowers et al., An economic analysis of an aggressive diagnostic strategy with single photon emission computed tomography myocardial perfusion imaging and early exercise stress testing in emergency department patients who present with chestpain but nondiagnostic electrocardiograms: Results from a randomized trial, ANN EMERG M, 35(1), 2000, pp. 17-25
Authors:
Newby, LK
Eisenstein, EL
Califf, RM
Thompson, TD
Nelson, CL
Peterson, ED
Armstrong, PW
Van de Werf, F
White, HD
Topol, EJ
Mark, DB
Citation: Lk. Newby et al., Cost effectiveness of early discharge after uncomplicated acute myocardialinfarction., N ENG J MED, 342(11), 2000, pp. 749-755
Citation: Rm. Califf et El. Eisenstein, Critical concepts in cost-effectiveness for cardiovascular specialists, AM HEART J, 140(6), 2000, pp. S143-S147